Page 16 - Michael Boyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

email article Adding a CTLA-4 checkpoint inhibitor to pembrolizumab (Keytruda) failed to improve survival in previously untreated patients with metastatic non-small cell lung cancer (NSCLC) and high PD-L1 expression levels, a phase III trial found. In KEYNOTE 598, the PD-1 checkpoint inhibitor pembrolizumab plus ipilimumab (Yervoy) yielded a median overall survival (OS) of 21.4 months in patients with a tumor proportion score (TPS) of 50% or greater, as compared to 21.9 months with pembrolizumab plus placebo (HR 1.08, 95% CI 0.85-1.37, P=0.74), reported Michael Boyer, MBBS, PhD, of the...

Adding ipilimumab to pembrolizumab does not improve efficacy and is associated with greater toxicity than pembrolizumab alone as first-line therapy for metastatic non-small cell lung cancer (NSCLC) for patients with a PD-L1 tumor proportion score of greater than or equal to 50% and no targetable EGFR or ALK aberrations.

Psyence Group Completes First Cultivation Cycle of Medical Psilocybin Mushrooms at Its Commercially Licensed Facility TORONTO, Jan. 29, 2021 — Psyence Group Inc. (“Psyence” or the “Company”) is pleased to announce that it has concluded its first cultivation and harvest cycle of natural medical psilocybin mushrooms. The mushrooms were grown, harvested, processed, and packed at its premium production facility in Lesotho which has been designed and built to the highest international standards. Jody Aufrichtig, Chief Executive Officer and Director of Psyence commented: “ This is an...

The 2020 WCLC Presidential Symposium features: National Lung Cancer Screening Program in Taiwan: The TALENT Study (Abstract 3309), Pan-Chyr Yang, M.D., from the National Taiwan University College of Medicine, Taipei/Taiwan. International Tailored Chemotherapy Adjuvant Trial: ITACA (Abstract 1820) with Dr. Silvio Novello, University of Torino at San Luigi Gonzaga Hospital, Orbassano, Italy. Surgical and Clinical Outcomes with Neoadjuvant Atezolizumab in Resectable Stage IB-IIIB NSCLC: LCMC3 Trial Primary Analysis (Abstract 3195) with Jay M. Lee, M.D., Ronald Reagan UCLA Medical Center in Los ...

Christmas For Calcasieu Toy Drive This Sunday We are truly winding down to Christmas. You blink your eyes and you could almost miss the big day. Here in Southwest Louisiana, Christmas is going to be a little different, and some families are still awaiting their homes being rebuilt or figuring out how they will make it through the winter. I got a hit the other day from a friend of mine Michael Boyer. He's the District Manager for the local McDonald's, and this guy is truly a community man. He advised me that he was able to get many sponsors and residents in the local area to help out for Chris...